Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Odorant-binding protein 2b (OBP2B) is a small, soluble, extracellular protein in humans, classified within the lipocalin family. It is encoded by the OBP2B gene and is thought to function in the binding and transport of small, hydrophobic, volatile molecules (odorants) across the nasal mucus to olfactory receptors, thus facilitating the sensory perception of smell. OBP2B is primarily active in the extracellular space and is predicted to play a role in chemosensory behavior. While closely related odorant-binding proteins are critical for olfaction in a variety of organisms, there is no direct evidence establishing OBP2B as a therapeutic target, nor is it currently associated with human disease or drug interactions. It does not belong to the major canonical receptor, enzyme, or transporter molecular target classes.
Not a therapeutic target; no mechanism of drug action reported or established for this protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Odorant-binding protein 2b (OBP2B).